TAM
HZNP

Tocqueville Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tocqueville Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,000
Closed -$47K – 1415
2014
Q2 		$47K Buy
+3,000
New +$42.8K ﹤0.01% 1327

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tocqueville Asset Management's HZNP Position: Q3 2014 in Review

Tocqueville Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2014, closing a stake of 3,000 shares — an estimated $47K sold.

Tocqueville Asset Management first reported a position in HZNP in Q2 2014 and held it in 1 quarter. The position peaked at $47K in Q2 2014. 120 funds tracked by Wall St. Rank hold HZNP as of Q3 2014.

  • Tocqueville Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2014 after selling out during the quarter.
  • Tocqueville Asset Management sold 3,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2014, an estimated $47K.
  • Tocqueville Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and held it in 1 quarter.
  • Tocqueville Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $47K in Q2 2014.
  • 120 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2014.

Based on Tocqueville Asset Management's 13F filing for Q3 2014, filed 30 Oct 2014.